Author | Keith T. Flaherty, MD | OncLive

Author | Keith T. Flaherty, MD

Articles

Dr. Flaherty on Second-Line Therapy for BRAF-Mutant Melanoma

September 24, 2019

Video

Keith T. Flaherty, MD, discusses treatment beyond frontline therapy for patients with BRAF-mutant relapsed/refractory melanoma.

Dr. Flaherty on the Rationale to Explore Triplet Therapy in BRAF V600E-Mutant Melanoma

August 01, 2019

Video

Keith T. Flaherty, MD, director, Henri and Belinda Termeer Center for Targeted Therapy and director of clinical research, Massachusetts General Hospital Cancer Center, and professor of medicine, Harvard Medical School, discusses the rationale to explore triplet therapy in BRAF V600-mutant melanoma.

Dr. Flaherty on the COLUMBUS Trial Updates in BRAF-Mutant Melanoma

July 24, 2019

Video

Keith T. Flaherty, MD, discusses an update on overall survival in COLUMBUS, a randomized phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma.

Dr. Flaherty Discusses BRAF Inhibitors in Melanoma

October 11, 2018

Video

Keith T. Flaherty, MD, director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, professor of medicine, Harvard Medical School, discusses BRAF inhibitors for the treatment of patients with melanoma.

x